289 related articles for article (PubMed ID: 6261070)
1. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.
Leysen JE; Awouters F; Kennis L; Laduron PM; Vandenberk J; Janssen PA
Life Sci; 1981 Mar; 28(9):1015-22. PubMed ID: 6261070
[No Abstract] [Full Text] [Related]
2. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
3. Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography.
Schotte A; de Bruyckere K; Janssen PF; Leysen JE
Brain Res; 1989 Oct; 500(1-2):295-301. PubMed ID: 2481562
[TBL] [Abstract][Full Text] [Related]
4. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
Laduron PM; Janssen PF; Leysen JE
Eur J Pharmacol; 1982 Jun; 81(1):43-8. PubMed ID: 7117369
[TBL] [Abstract][Full Text] [Related]
5. Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors.
Muller P; Seeman P
Life Sci; 1977 Dec; 21(12):1751-8. PubMed ID: 203807
[No Abstract] [Full Text] [Related]
6. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.
Leysen JE; Niemegeers CJ; Van Nueten JM; Laduron PM
Mol Pharmacol; 1982 Mar; 21(2):301-14. PubMed ID: 7099138
[No Abstract] [Full Text] [Related]
7. Distinct autoradiographic labelling of serotonin 5-HT2 receptors, alpha 1-adrenoceptors and histamine-H1 receptors and of tetrabenazine-displaceable ketanserin binding sites in rodent brain with [125I]7-amino-8-iodo-ketanserin.
Schotte A; Leysen JE
Eur J Pharmacol; 1988 Jan; 145(2):213-6. PubMed ID: 2832189
[TBL] [Abstract][Full Text] [Related]
8. Reduced binding of [3H]ketanserin to cortical 5-ht2 receptors in senile dementia of the Alzheimer type.
Reynolds GP; Arnold L; Rossor MN; Iversen LL; Mountjoy CQ; Roth M
Neurosci Lett; 1984 Jan; 44(1):47-51. PubMed ID: 6717852
[TBL] [Abstract][Full Text] [Related]
9. Alpha 1 adrenergic receptors in the porcine pituitary neurointermediate lobe: detection with [3H]ketanserin.
Battaglia G; Shannon M; Borgundvaag B; Titeler M
J Recept Res; 1984; 4(7):713-26. PubMed ID: 6098679
[TBL] [Abstract][Full Text] [Related]
10. pH-dependent modulation of agonist interactions with [3H]-ketanserin-labelled S2 serotonin receptors.
Battaglia G; Shannon M; Borgundvaag B; Titeler M
Life Sci; 1983 Nov; 33(20):2011-6. PubMed ID: 6645787
[TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
[TBL] [Abstract][Full Text] [Related]
12. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
Rinaldi-Carmona M; Congy C; Santucci V; Simiand J; Gautret B; Neliat G; Labeeuw B; Le Fur G; Soubrie P; Breliere JC
J Pharmacol Exp Ther; 1992 Aug; 262(2):759-68. PubMed ID: 1501121
[TBL] [Abstract][Full Text] [Related]
14. Ketanserin: a selective antagonist of 5-HT2 serotoninergic receptors.
Van Nueten JM; Leysen JE; Schuurkes JA; Vanhoutte PM
Lancet; 1983 Feb; 1(8319):297-8. PubMed ID: 6130314
[No Abstract] [Full Text] [Related]
15. CGS 18102A, a benzopyranopyridine anxiolytic with 5-HT1 agonist and 5-HT2 antagonist properties.
Sills MA; Bennett DA; Lovell RA; Liebman JM; Wood PL; Glaeser BS; Williams M; Hutchison AJ
Prog Clin Biol Res; 1990; 361():469-75. PubMed ID: 1981265
[No Abstract] [Full Text] [Related]
16. Estradiol-induced increase of specific [3H]ketanserin binding sites on rat uterine membranes.
Ichida S; Hayashi T; Kita T; Murakami T
Eur J Pharmacol; 1985 Feb; 108(3):257-64. PubMed ID: 3157585
[TBL] [Abstract][Full Text] [Related]
17. [3H]ketanserin labels serotonin 5-HT2 and alpha 1-adrenergic receptors in human brain cortex.
Hoyer D; Vos P; Closse A; Palacios JM; Engel G; Davies H
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S48-50. PubMed ID: 2446070
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
19. DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles.
Tam SW; Steinfels GF; Gilligan PJ; Schmidt WK; Cook L
J Pharmacol Exp Ther; 1992 Dec; 263(3):1167-74. PubMed ID: 1361572
[TBL] [Abstract][Full Text] [Related]
20. In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserin.
Wouters W; Janssen CG; Van Dun J; Thijssen JB; Laduron PM
J Med Chem; 1986 Sep; 29(9):1663-8. PubMed ID: 3746815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
